By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc. (MIRA)

NASDAQ Currency in USD
$1.66
+$0.14
+9.21%
Last Update: 11 Sept 2025, 20:00
$31.66M
Market Cap
-3.68
P/E Ratio (TTM)
Forward Dividend Yield
$0.73 - $2.56
52 Week Range

MIRA Stock Price Chart

Explore MIRA Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze MIRA price movements and trends.

MIRA Company Profile

Discover essential business fundamentals and corporate details for MIRA Pharmaceuticals, Inc. (MIRA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - General

IPO Date

14 Aug 2023

Employees

2.00

CEO

Erez Aminov

Description

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.

MIRA Financial Timeline

Browse a chronological timeline of MIRA Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 Nov 2025

EPS estimate is -$0.11.

Earnings released on 14 Aug 2025

EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%.

Earnings released on 14 May 2025

EPS came in at -$0.11 surpassing the estimated -$0.15 by +26.67%.

Earnings released on 28 Mar 2025

EPS came in at -$0.15 surpassing the estimated -$0.29 by +48.28%, while revenue for the quarter reached $11.16M .

Earnings released on 12 Nov 2024

EPS came in at -$0.14 surpassing the estimated -$0.18 by +22.22%.

Earnings released on 13 Aug 2024

EPS came in at -$0.11 falling short of the estimated -$0.10 by -10.00%.

Earnings released on 13 May 2024

EPS came in at -$0.12 falling short of the estimated -$0.10 by -20.00%.

Earnings released on 1 Apr 2024

EPS came in at -$0.39 falling short of the estimated -$0.23 by -70.23%.

Earnings released on 13 Nov 2023

EPS came in at -$0.26 falling short of the estimated -$0.08 by -225.00%.

Earnings released on 15 Sept 2023

EPS came in at -$0.10 .

Earnings released on 31 Mar 2023

EPS came in at -$0.09 .

Earnings released on 31 Dec 2022

EPS came in at -$43.86 .

Earnings released on 30 Sept 2022

EPS came in at -$0.12 .

Earnings released on 30 Jun 2022

EPS came in at -$0.16 .

Earnings released on 31 Mar 2022

EPS came in at -$0.10 .

Earnings released on 31 Mar 2021

EPS came in at -$0.00 .

MIRA Stock Performance

Access detailed MIRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run